Salesforce is expecting to exit the file storage and sharing platform Dropbox, which filed for an IPO after having raised more than $1.7bn in debt and equity financing.

Ofer subsidiary OG Tech Ventures has bought the Santander-backed hospitality payment technology provider for an undisclosed amount.

The diabetes treatment developer will target at least $400m from a Hong Kong offering that will allow WuXi PharmaTech to exit.

Lundbeck and Novo-backed nausea and vomiting therapy developer Acacia Pharma raised $49.6m in its initial global offering in Brussels.

Chorus, which had raised seed capital from Chernin Group and UTA Ventures, has elected to shut down its group fitness app shortly after its launch.

The immuno-oncology therapy developer, which is backed by Novo, Sanofi, EMS and Seattle Genetics, has raised $77m in venture funding.

S&P Global has agreed to acquire portfolio company Kensho, an AI-equipped information software provider, in a deal that will also allow GV to exit.

S&P Global is set to acquire its portfolio company Kensho, a spinout from Harvard and MIT, in the largest such deal involving an AI developer to date.

Rare disease therapy developer Homology Medicines has raised approximately $130m in VC funding from investors including Novartis.

The corporate-backed ride hailing platform, currently valued at $5bn, has met with Indonesia Stock Exchange's CEO to discuss an initial public offering.